- Home
- PYPD vs LSH Comparison
PYPD vs LSH Comparison
Compare PYPD & LSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- LSH
- Stock Information
- Founded
- PYPD 2008
- LSH 2018
- Country
- PYPD Israel
- LSH United States
- Employees
- PYPD N/A
- LSH N/A
- Industry
- PYPD Medical/Dental Instruments
- LSH
- Sector
- PYPD Health Care
- LSH
- Exchange
- PYPD Nasdaq
- LSH NYSE
- Market Cap
- PYPD 19.4M
- LSH 20.3M
- IPO Year
- PYPD 2020
- LSH 2024
- Fundamental
- Price
- PYPD $3.30
- LSH $2.02
- Analyst Decision
- PYPD Strong Buy
- LSH
- Analyst Count
- PYPD 2
- LSH 0
- Target Price
- PYPD $10.50
- LSH N/A
- AVG Volume (30 Days)
- PYPD 49.0K
- LSH 76.4K
- Earning Date
- PYPD 02-12-2025
- LSH 02-01-2025
- Dividend Yield
- PYPD N/A
- LSH N/A
- EPS Growth
- PYPD N/A
- LSH N/A
- EPS
- PYPD N/A
- LSH N/A
- Revenue
- PYPD N/A
- LSH $18,248,233.00
- Revenue This Year
- PYPD N/A
- LSH N/A
- Revenue Next Year
- PYPD N/A
- LSH N/A
- P/E Ratio
- PYPD N/A
- LSH N/A
- Revenue Growth
- PYPD N/A
- LSH 28.38
- 52 Week Low
- PYPD $2.37
- LSH $1.78
- 52 Week High
- PYPD $7.00
- LSH $5.37
- Technical
- Relative Strength Index (RSI)
- PYPD 55.20
- LSH N/A
- Support Level
- PYPD $2.93
- LSH N/A
- Resistance Level
- PYPD $3.35
- LSH N/A
- Average True Range (ATR)
- PYPD 0.24
- LSH 0.00
- MACD
- PYPD 0.04
- LSH 0.00
- Stochastic Oscillator
- PYPD 93.15
- LSH 0.00
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About LSH LAKESIDE HOLDING LTD
Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.